Abstract
Translational research is often described as “bench to bedside” because it builds on basic science findings to “translate” discoveries into potential interventions or therapeutics that can be tested in clinical trials and adopted into healthcare practice. This introductory chapter offers working definitions of the various phases of research spanning from basic research to clinical testing and ultimately to the implementation of these endeavors into evidence-based patient care. There are multiple challenges in moving from basic science to clinical trials and from clinical research into routine application in healthcare delivery. There are also clearly diverging interests of academics (creation of knowledge, education of the future workforce) and industry (meeting market needs and protecting exclusivity to generate revenue and increase shareholder value). However, academia and industry share the common goal of finding cures for patients in need. Whether patient care is advanced through industry-funded research within an academic laboratory or industry licensing of an academic patent is not important from the patient’s perspective. What will benefit patients the most in the long run is the translation of novel therapies into clinical testing with subsequent translation of the most effective therapies into patient care, with the long-term goal of improving public health outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Notes
- 1.
1Colleen Le Prell was the principal investigator on the contract between Sound Pharmaceuticals, Inc. and the University of Florida.
- 2.
Colleen Le Prell is an inventor on these patents; see references for detailed information.
References
Abi-Hachem, R. N., Zine, A., & Van De Water, T. R. (2010). The injured cochlea as a target for inflammatory processes, initiation of cell death pathways and application of related otoprotectives strategies. Recent Patents on CNS Drug Discovery, 5(2), 147–163.
Agarwal, L., & Pothier, D. D. (2009). Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss. Cochrane Database of Systematic Reviews, 4, CD003422.
Agrawal, Y., Platz, E. A., & Niparko, J. K. (2008). Prevalence of hearing loss and differences by demographic characteristics among US adults: Data from the National Health and Nutrition Examination Survey, 1999–2004. Archives of Internal Medicine, 168(14), 1522–1530.
Agrawal, Y., Platz, E. A., & Niparko, J. K. (2009). Risk factors for hearing loss in US adults: Data from the National Health and Nutrition Examination Survey, 1999 to 2002. Otology & Neurotology, 30(2), 139–145.
Altman, D. G. (2000). Appendix 1: Confidence intervals. In D. L. Sackett, S. E. Straus, W. S. Richardson, W. Rosenberg, & R. B. Hauynes (Eds.), Evidence-based medicine: How to practice and teach EBM (pp. 233–243). Edinburgh: Churchill Livingstone.
Anderson, J. M., & Campbell, K. (2015). Assessment of interventions to prevent drug-induced hearing loss. In J. M. Miller, C. G. Le Prell, & L. P. Rybak (Eds.), Oxidative stress in applied basic research and clinical practice: Free radicals in ENT pathology (pp. 243–269). New York: Humana Press.
Apel, K. (2011). Science is an attitude: A response to Kamhi. Language, Speech, and Hearing Services in Schools, 42(1), 65–68; discussion 88–93.
Badri, R., Siegel, J. H., & Wright, B. A. (2011). Auditory filter shapes and high-frequency hearing in adults who have impaired speech in noise performance despite clinically normal audiograms. The Journal of the Acoustical Society of America, 129(2), 852–863.
Bernstein Ratner, N. (2006). Evidence-based practice: An examination of its ramifications for the practice of speech-language pathology. Language, Speech, and Hearing Services in Schools, 37(4), 257–267.
Bernstein Ratner, N. (2011). Some pragmatic tips for dealing with clinical uncertainty. Language, Speech, and Hearing Services in Schools, 42(1), 77–80; discussion 88–93.
Bertha, S. L. (1996). Academic research: Policies and practice. Journal of Ethnopharmacology, 51(1–3), 59–73.
Bhargava, D., Al-Saidi, Y., Bhargava, K., & Al-Abri, R. (2011). Information mastery, effective health care, evidence-based practice and the otolaryngologist. Sultan Qaboos University Medical Sciences Journal, 11(4), 492–496.
Bonny, C. (2009). Cell-permeable peptide inhibitors of the JNK signal transduction pathway. US Patent No. 7,635,681. United States Patent Trademark Office.
Brant, L. J., & Fozard, J. L. (1990). Age changes in pure-tone hearing thresholds in a longitudinal study of normal human aging. The Journal of the Acoustical Society of America, 88(2), 813–820.
Bush, V. (1945). Science: The endless frontier. A report to the president by Vannevar Bush, director of the Office of Scientific Research and Development. http://www.nsf.gov/about/history/nsf50/vbush1945_content.jsp. Accessed July 9, 2015.
Butler, D. (2008). Translational research: Crossing the valley of death. Nature, 453(7197), 840–842.
Campbell, K. C. M. (2001). Therapeutic use of d-methionine to reduce the toxicity of ototoxic drugs, noise, and radiation. US Patent No. 6,265,386. United States Patent Trademark Office.
Campbell, K. C. M. (2008). Therapeutic use of methionine-derivitives to reduce the toxicity of noise. US Patent No. 7,423,065. United States Patent Trademark Office.
Campbell, K. C. M., & Le Prell, C. G. (2012). Potential therapeutic agents. Seminars in Hearing, 33(1), 97–113.
Carhart, R. (1951). Basic principles of speech audiometry. Acta Oto-Laryngologica, 40(1–2), 62–71.
Carhart, R., & Tillman, T. W. (1970). Interaction of competing speech signals with hearing losses. Archives of Otolaryngology, 91(3), 273–279.
Choi, Y.-H., Hu, H., Mukherjee, B., Miller, J., & Park, S. K. (2012). Environmental cadmium and lead exposures and hearing loss in U.S. adults: The National Health and Nutrition Examination Survey, 1999 to 2004. Environmental Health Perspectives, 120(11), 1544–1550.
Choi, Y.-H., Miller, J. M., Tucker, K. L., Hu, H., & Park, S. K. (2014). Antioxidant vitamins and magnesium and the risk of hearing loss in the US general population. American Journal of Clinical Nutrition, 99(1), 148–155.
Coe, R. (2002). It’s the effect size, stupid: What effect size is and why it is important. Paper presented at the Annual Conference of the British Educational Research Association, University of Exeter, England, September 12–14, 2002. http://www.leeds.ac.uk/educol/documents/00002182.htm. Accessed July 15, 2015.
Cohen, D. (1988). Statistical power analysis for the behavioral sciences, 2nd ed. Hillsdale, NJ: Lawrence Erlbaum.
Coller, B. S., & Califf, R. M. (2009). Traversing the valley of death: A guide to assessing prospects for translational success. Science Translational Medicine, 1(10), 10cm19.
Cox, R. M. (2005). Evidence-based practice in provision of amplification. Journal of the American Academy of Audiology, 16(7), 419–438.
Crowley, W. F., Jr., & Gusella, J. F. (2009). Changing models of biomedical research. Science Translational Medicine, 1(1), 1cm1.
Cruickshanks, K. J., Wiley, T. L., Tweed, T. S., Klein, B. E., Klein, R., et al. (1998). Prevalence of hearing loss in older adults in Beaver Dam, Wisconsin. The Epidemiology of Hearing Loss Study. American Journal of Epidemiology, 148(9), 879–886.
Curhan, S. G., Shargorodsky, J., Eavey, R., & Curhan, G. C. (2012). Analgesic use and the risk of hearing loss in women. American Journal of Epidemiology, 176(6), 544–554.
Dawes, M., Davies, P., Gray, A., Mant, J., Seers, K., & Snowball, R. (2005). Evidence based practice. Philadelphia: Elsevier.
De Ridder, D., Vanneste, S., Elgoyhen, A. B., Langguth, B., & de Nora, M. (2015). All treatments in tinnitus are experimental, controversial, and futuristic: A comment on “Experimental, controversial, and futuristic treatments for chronic tinnitus” by Folmer et al. (2014). Journal of the American Academy of Audiology, 26(6), 595–597.
Dobie, R. A. (1999). A review of randomized clinical trials in tinnitus. Laryngoscope, 109(8), 1202–1211.
Dobie, R. A., & Clark, W. W. (2014). Exchange rates for intermittent and fluctuating occupational noise: A systematic review of studies of human permanent threshold shift. Ear and Hearing, 35(1), 86–96.
Dobie, R. A., & Clark, W. W. (2015). Response to Suter and NIOSH. Ear and Hearing, 36(4), 492–495.
Dollaghan, C. A. (2004). Evidence-based practice in communication disorders: What do we know, and when do we know it? Journal of Communication Disorders, 37(5), 391–400.
Dougherty, D., & Conway, P. H. (2008). The “3T’s” road map to transform US health care: The “how” of high-quality care. JAMA, 299(19), 2319–2321.
Duijvestijn, J. A., Anteunis, L. J., Hoek, C. J., Van Den Brink, R. H., Chenault, M. N., & Manni, J. J. (2003). Help-seeking behaviour of hearing-impaired persons aged > or = 55 years: Effect of complaints, significant others and hearing aid image. Acta Oto-Laryngologica, 123(7), 846–850.
Ehrismann, D., & Patel, D. (2015). University-industry collaborations: Models, drivers and cultures. Swiss Medical Weekly, 145, w14086.
Fabry, D. A., Davila, E. P., Arheart, K. L., Serdar, B., Dietz, N. A., et al. (2011). Secondhand smoke exposure and the risk of hearing loss. Tobacco Control, 20(1), 82–85.
Fears, R., van der Meer, J. W., & ter Meulen, V. (2010). Translational medicine policy issues in infectious disease. Science Translational Medicine, 2(14), 14cm2.
Ferguson, C. J. (2009). An effect size primer: A guide for clinicians and researchers. Professional Psychology: Research and Practice, 40(5), 532–538.
Finn, P. (2011). Critical thinking: knowledge and skills for evidence-based practice. Language, Speech, and Hearing Services in Schools, 42(1), 69–72; discussion 88–93.
Folmer, R. L., Theodoroff, S. M., Martin, W. H., & Shi, Y. (2014). Experimental, controversial, and futuristic treatments for chronic tinnitus. Journal of the American Academy of Audiology, 25(1), 106–125.
Füllgrabe, C., Moore, B. C. J., & Stone, M. A. (2014). Age-group differences in speech identification despite matched audiometrically normal hearing: Contributions from auditory temporal processing and cognition. Frontiers in Aging Neuroscience, 6, Article 347.
Gopinath, B., Flood, V. M., McMahon, C. M., Burlutsky, G., Spankovich, C., et al. (2011). Dietary antioxidant intake is associated with the prevalence but not incidence of age-related hearing loss. The Journal of Nutrition, Health, & Aging, 15(10), 896–900.
Guitton, M., Puel, J.-L., Pujol, R., Ruel, J., & Wang, J. (2015). Methods for the treatment of tinnitus induced by cochlear excitotoxicity. US Patent No. 9,072,662. United States Patent Trademark Office.
Hammerstedt, R. H., & Blach, E. L. (2008). Commercialization of basic research from within the university and return of value to the public. Animal Reproduction Science, 105(1–2), 158–178.
Handelsman, K. (2009). A translational research niche for small business innovation research grants. Science Translational Medicine, 1(5), 5cm6.
Henderson, E., Testa, M. A., & Hartnick, C. (2011). Prevalence of noise-induced hearing-threshold shifts and hearing loss among US youths. Pediatrics, 127(1), e39–e46.
Huth, M. E., Ricci, A. J., & Cheng, A. G. (2011). Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection. International Journal of Otolaryngology, 2011, Article ID 937861.
Johnson, C. L., Dohrmann, S. M., Burt, V. L., & Mohadjer, L. K. (2014). No. 162. National Health and Nutrition Examination Survey: Sample design, 2011–2014. National Center for Health Statistics. Vital and Health Statistics Series; Series 2. Data Evaluation and Methods Research. http://www.cdc.gov/nchs/products/series/series02.htm
Kesselheim, A. S., & Avorn, J. (2005). University-based science and biotechnology products: Defining the boundaries of intellectual property. JAMA, 293(7), 850–854.
Kil, J., & Lynch, E. (2010). Methods for treating hearing loss. US Patent No. 7,820,640. United States Patent Trademark Office.
Kil, J., Lynch, E. D., Griffiths, S., Lobarinas, E., Spankovich, C., et al. (2014). Efficacy of SPI-1005 for prevention of noise-induced hearing loss: Phase 2 clinical trial results. Otolaryngology–Head and Neck Surgery, 151(1 Suppl.), 83–84.
Kneller, R., Mongeon, M., Cope, J., Garner, C., & Ternouth, P. (2014). Industry–university collaborations in Canada, Japan, the UK and USA—With emphasis on publication freedom and managing the intellectual property lock-up problem. PLoS ONE, 9(3), Article e90302.
Knowles, S. M. (2010). Fixing the legal framework for pharmaceutical research. Science, 327, 1083–1084.
Korn, D., & Heinig, S. J. (2005). Biotechnology products and university-based science. JAMA, 293(23), 2862–2863; author reply 2863.
Kramer, S., Dreisbach, L., Lockwood, J., Baldwin, K., Kopke, R. D., et al. (2006). Efficacy of the antioxidant N-acetylcysteine (NAC) in protecting ears exposed to loud music. Journal of the American Academy of Audiology, 17, 265–278.
Lalwani, A. K., Liu, Y. H., & Weitzman, M. (2011). Second hand smoke is associated with sensorineural hearing loss in adolescents. Archives of Otolaryngology–Head and Neck Surgery, 137(7), 655–662.
Langguth, B., & Elgoyhen, A. B. (2012). Current pharmacological treatments for tinnitus. Expert Opinion on Pharmacotherapy, 13(17), 2495–2509.
Laurell, G., & Pierre, P. V. (2015). Hearing loss after cisplatin: Oxidative stress pathways and potential for protection. In J. M. Miller, C. G. Le Prell, & L. P. Rybak (Eds.), Oxidative stress in applied basic research and clinical practice: Free radicals in ENT pathology (pp. 217–241). New York: Humana Press.
Lempert, P. (2005). Biotechnology products and university-based science. JAMA, 293(23), 2861–2862; author reply 2863.
Le Prell, C. G., & Bao, J. (2012). Prevention of noise-induced hearing loss: Potential therapeutic agents. In C. G. Le Prell, D. Henderson, R. R. Fay, & A. N. Popper (Eds.), Noise-induced hearing loss: Scientific advances (pp. 285–338). New York: Springer Science+Business Media.
Le Prell, C. G., & Lobarinas, E. (2015). Strategies for assessing antioxidant efficacy in clinical trials. In J. M. Miller, C. G. Le Prell, & L. P. Rybak (Eds.), Oxidative stress in applied basic research and clinical practice: Free radicals in ENT pathology (pp. 163–192). New York: Humana Press.
Le Prell, C. G., Hughes, L. F., & Miller, J. M. (2007a). Free radical scavengers vitamins A, C, and E plus magnesium reduce noise trauma. Free Radical Biology and Medicine, 42(9), 1454–1463.
Le Prell, C. G., Yamashita, D., Minami, S., Yamasoba, T., & Miller, J. M. (2007b). Mechanisms of noise-induced hearing loss indicate multiple methods of prevention. Hearing Research, 226(1–2), 22–43.
Le Prell, C. G., Dolan, D. F., Bennett, D. C., & Boxer, P. A. (2011a). Nutrient treatment and achieved plasma levels: Reduction of noise-induced hearing loss at multiple post-noise test times. Translational Research, 158(1), 54–70.
Le Prell, C. G., Gagnon, P. M., Bennett, D. C., & Ohlemiller, K. K. (2011b). Nutrient-enhanced diet reduces noise-induced damage to the inner ear and hearing loss. Translational Research, 158, 38–53.
Le Prell, C. G., Johnson, A.-C., Lindblad, A.-C., Skjönsberg, A., Ulfendahl, M., et al. (2011c). Increased vitamin plasma levels in Swedish military personnel treated with nutrients prior to automatic weapon training. Noise & Health, 13, 432–443.
Le Prell, C. G., Ojano-Dirain, C. P., Rudnick, E. W., Nelson, M. A., deRemer, S., et al. (2014). Assessment of nutrient supplement to reduce gentamicin-induced ototoxicity. Journal of the Association for Research in Otolaryngology, 15(3), 375–393.
Le Prell, C. G., Fulbright, A., Spankovich, C., Griffiths, S., Lobarinas, E., et al. (2016). Dietary supplement comprised of β-carotene, vitamin C, vitamin E, and magnesium: failure to prevent music-induced temporary threshold shift. Audiology and Neurotology EXTRA, 6, 20–39.
Li, C. M., Zhang, X., Hoffman, H. J., Cotch, M. F., Themann, C. L., & Wilson, M. R. (2014). Hearing impairment associated with depression in US adults, National Health and Nutrition Examination Survey 2005–2010. JAMA Otolaryngology–Head and Neck Surgery, 140(4), 293–302.
Lim, D. J., & Melnick, W. (1971). Acoustic damage of the cochlea. A scanning and transmission electron microscopic observation. Archives of Otolaryngology, 94(4), 294–305.
Limb, C. J. (2011). The need for evidence in an anecdotal world. Trends in Amplification, 15(1), 3–4.
Lin, F. R. (2011). Hearing loss and cognition among older adults in the United States. Journals of Gerontology A: Biological Sciences and Medical Sciences, 66(10), 1131–1136.
Lin, F. R., Maas, P., Chien, W., Carey, J. P., Ferrucci, L., & Thorpe, R. (2012). Association of skin color, race/ethnicity, and hearing loss among adults in the USA. Journal of the Association for Research in Otolaryngology, 13(1), 109–117.
Lindblad, A. C., Rosenhall, U., Olofsson, A., & Hagerman, B. (2011). The efficacy of N-acetylcysteine to protect the human cochlea from subclinical hearing loss caused by impulse noise: A controlled trial. Noise Health, 13(55), 392–401.
Lynch, E. D., & Kil, J. (2009). Development of ebselen, a glutathione peroxidase mimic, for the prevention and treatment of noise-induced hearing loss. Seminars in Hearing, 30, 47–55.
Mahboubi, H., Zardouz, S., Oliaei, S., Pan, D., Bazargan, M., & Djalilian, H. R. (2013). Noise-induced hearing threshold shift among US adults and implications for noise-induced hearing loss: National Health and Nutrition Examination Surveys. European Archives of Oto-Rhino-Laryngology, 270, 461–467.
Marks, L. A. (1991). Medical technology transfer: the inventor’s perspective. Biomedical Instrumentation & Technology, 25(1), 35–41.
Martin, J. B. (2002). Academic-industrial collaboration: The good, the bad, and the ugly. Transactions of the American Clinical and Climatological Association, 113, 227–239; discussion 239–240.
McKibbon, A. (1999). PDQ: Evidence-based principles and practice. Hamilton, ON, Canada: B. C. Decker.
Meline, T., & Paradiso, T. (2003). Evidence-based practice in schools: Evaluating research and reducing barriers. Language, Speech, and Hearing Services in Schools, 34(4), 273–283.
Meslin, E. M., Blasimme, A., & Cambon-Thomsen, A. (2013). Mapping the translational science policy ‘valley of death’. Clinical and Translational Medicine, 2(1), 14.
Miller, J. M., Le Prell, C. G., Schacht, J., & Prieskorn, D. (2011). Composition and method of treating hearing loss. US Patent No. 7,951,845. United States Patent Trademark Office.
Miller, J. M., Le Prell, C. G., Schacht, J., & Prieskorn, D. (2012). Composition and method of treating hearing loss. US Patent No. 8,338,398. United States Patent Trademark Office.
Miller, J. M., Le Prell, C. G., Schacht, J., & Prieskorn, D. (2015). Composition for treating hearing loss. US Patent No. 8,927,528. United States Patent Trademark Office.
Milne, C. P., & Kaitin, K. I. (2009). Translational medicine: An engine of change for bringing new technology to community health. Science Translational Medicine, 1(5), 5cm5.
Mitchell, P., Gopinath, B., Wang, J. J., McMahon, C. M., Schneider, J., et al. (2011). Five-year incidence and progression of hearing impairment in an older population. Ear and Hearing, 32(2), 251–257.
Moodie, S. T., Kothari, A., Bagatto, M. P., Seewald, R., Miller, L. T., & Scollie, S. D. (2011). Knowledge translation in audiology: Promoting the clinical application of best evidence. Trends in Amplification, 15(1), 5–22.
Moran, N. (2007). Public sector seeks to bridge ‘valley of death.’ Nature Biotechnology, 25(3), 266.
Morata, T. C., Themann, C. L., Byrne, D. C., Davis, R. R., Murphy, W. J., & Stephenson, M. R. (2015). Letter to the Editor: Scientific rigor required for a re-examination of exchange rate for occupational noise measurements re: Dobie, R.A., & Clark, W.W. (2014) Exchange rates for intermittent and fluctuating occupational noise: A systematic review of studies of human permanent threshold shift, Ear Hear, 35, 86–96. Ear and Hearing, 36(4), 488–491.
Moreira, T., & Palladino, P. (2011). ‘Population laboratories’ or ‘laboratory populations’? Making sense of the Baltimore Longitudinal Study of Aging, 1965–1987. Studies in History and Philosophy of Biological and Biomedical Sciences, 42(3), 317–327.
Moses, H., 3rd, Dorsey, E. R., Matheson, D. H., & Thier, S. O. (2005). Financial anatomy of biomedical research. JAMA, 294(11), 1333–1342.
Nail-Chiwetalu, B. J., & Bernstein Ratner, N. (2006). Information literacy for speech-language pathologists: A key to evidence-based practice. Language, Speech, and Hearing Services in Schools, 37(3), 157–167.
Nash, S. D., Cruickshanks, K. J., Klein, R., Klein, B. E., Nieto, F. J., et al. (2011). The prevalence of hearing impairment and associated risk factors: The Beaver Dam Offspring Study. Archives of Otolaryngology–Head and Neck Surgery, 137(5), 432–439.
NCT00808470. Micronutrients to prevent noise-induced hearing loss. http://clinicaltrials.gov/ct2/show/NCT00808470. Accessed May 8, 2012.
NCT01444846. Otoprotection with SPI-1005. http://clinicaltrials.gov/ct2/show/NCT01444846. Accessed January 11, 2013.
NCT02132130. Safety, tolerability and efficacy for CGF166 in patients with bilateral severe-to-profound hearing loss. http://clinicaltrials.gov/ct2/show/NCT02132130. Accessed August 4, 2015.
Neitzel, R., Somers, S., & Seixas, N. (2006). Variability of real-world hearing protector attenuation measurements. Annals of Occupational Hygiene, 50(7), 679–691.
Nelsen, L. L. (2004). A US perspective on technology transfer: The changing role of the university. Nature, 5, 1–5.
Niskar, A. S., Kieszak, S. M., Holmes, A., Esteban, E., Rubin, C., & Brody, D. J. (1998). Prevalence of hearing loss among children 6 to 19 years of age: The Third National Health and Nutrition Examination Survey. JAMA, 279(14), 1071–1075.
Occupational Safety and Health Administration (OSHA). (1983). 29 CFR 1910.95. Occupational Noise Exposure; Hearing Conservation Amendment; Final Rule, effective 8 March 1983. U.S. Department of Labor, Occupational Safety & Health Administration.
Ogilvie, D., Craig, P., Griffin, S., Macintyre, S., & Wareham, N. J. (2009). A translational framework for public health research. BMC Public Health, 9, 116.
Ohlemiller, K. K., Wright, J. S., & Dugan, L. L. (1999). Early elevation of cochlear reactive oxygen species following noise exposure. Audiology and Neuro-Otology, 4(5), 229–236.
Patino, R. (2009). Intellectual property rights and research disclosure in the university environment: Preserving the commercialization option and optimizing market interest. Journal of the American Association of Laboratory Animal Science, 48(2), 138–143.
Peters, C. P. (2004). Fundamentals of the prescription drug market. National Health Policy Forum. http://www.nhpf.org/library/background-papers/BP_RxIndustry_08-24-04.pdf
Phillips, J. S., & Westerberg, B. (2011). Intratympanic steroids for Meniere’s disease or syndrome. Cochrane Database of Systematic Reviews (7), CD008514.
Plomp, R. (1986). A signal-to-noise ratio model for the speech-reception threshold of the hearing impaired. Journal of Speech and Hearing Research, 29(2), 146–154.
Poirrier, A. L., Pincemail, J., Van Den Ackerveken, P., Lefebvre, P. P., & Malgrange, B. (2010). Oxidative stress in the cochlea: An update. Current Medicinal Chemistry, 17(30), 3591–3604.
Quist-Hanssen, S., Thorud, E., & Aasand, G. (1979). Noise-induced hearing loss and the comprehension of speech in noise. Acta Oto-Laryngologica Supplementum, 360, 90–95.
Rubio, D. M., Schoenbaum, E. E., Lee, L. S., Schteingart, D. E., Marantz, P. R., et al. (2010). Defining translational research: Implications for training. Academic Medicine, 85(3), 470–475.
Rybak, L. P., & Brenner, M. J. (2015). Aminoglycoside-induced oxidative stress: Pathways and protection. In J. M. Miller, C. G. Le Prell, & L. P. Rybak (Eds.), Oxidative stress in applied basic research and clinical practice: Free radicals in ENT pathology (pp. 195–216). New York: Humana Press.
Rybak, L. P., Mukherjea, D., Jajoo, S., & Ramkumar, V. (2009). Cisplatin ototoxicity and protection: Clinical and experimental studies. Tohoku Journal of Experimental Medicine, 219(3), 177–186.
Salmani Nodoushan, M., Mehrparvar, A. H., Torab Jahromi, M., Safaei, S., & Mollasadeghi, A. (2014). Training in using earplugs or using earplugs with a higher than necessary noise reduction rating? A randomized clinical trial. International Journal of Occupational and Environmental Medicine, 5(4), 187–193.
Schulz, T. Y. (2011). Individual fit-testing of earplugs: A review of uses. Noise Health, 13(51), 152–162.
Shargorodsky, J., Curhan, S. G., Eavey, R., & Curhan, G. C. (2010a). A prospective study of cardiovascular risk factors and incident hearing loss in men. Laryngoscope, 120(9), 1887–1891.
Shargorodsky, J., Curhan, S. G., Curhan, G. C., & Eavey, R. (2010b). Change in prevalence of hearing loss in US adolescents. JAMA, 304(7), 772–778.
Shargorodsky, J., Curhan, S. G., Eavey, R., & Curhan, G. C. (2010c). A prospective study of vitamin intake and the risk of hearing loss in men. Otolaryngology–Head and Neck Surgery, 142(2), 231–236.
Sleight, P. (2000). Debate: Subgroup analyses in clinical trials: Fun to look at—but don’t believe them! Current Controlled Trials in Cardiovascular Medicine, 1(1), 25–27.
Spankovich, C., & Le Prell, C. G. (2013). Healthy diets, healthy hearing: National Health and Nutrition Examination Survey, 1999–2002. International Journal of Audiology, 52(6), 369–276.
Spankovich, C., & Le Prell, C. G. (2014). Associations between dietary quality, noise, and hearing: Data from the National Health and Nutrition Examination Survey, 1999–2002. International Journal of Audiology, 53(11), 796–809.
Staecker, H. (2008). Drug delivery to the inner ear and methods of using same. US Patent No. 7,387,614. United States Patent Trademark Office.
Staecker, H., Maxwell, K. S., Morris, J. R., van de Heyning, P., Morawski, K., et al. (2015). Selecting appropriate dose regimens for AM-101 in the intratympanic treatment of acute inner ear tinnitus. Audiology and Neuro-Otology, 20(3), 172–182.
Suckfuell, M., Canis, M., Strieth, S., Scherer, H., & Haisch, A. (2007). Intratympanic treatment of acute acoustic trauma with a cell-permeable JNK ligand: A prospective randomized phase I/II study. Acta Oto-Laryngologica, 127(9), 938–942.
Suckfuell, M., Lisowska, G., Domka, W., Kabacinska, A., Morawski, K., et al. (2014). Efficacy and safety of AM-111 in the treatment of acute sensorineural hearing loss: A double-blind, randomized, placebo-controlled phase II study. Otology & Neurotology, 35(8), 1317–1326.
Suter, A. H. (2015). Letter to the Editor: An alternative interpretation of issues surrounding the exchange rates re: Dobie, R.A., & Clark, W.W. (2014) Exchange rates for intermittent and fluctuating occupational noise: A systematic review of studies of human permanent threshold shift, Ear Hear, 35, 86–96. Ear and Hearing, 36(4), 485–487.
Tremblay, K. L., Pinto, A., Fischer, M. E., Klein, B. E. K., Klein, R., et al (2015). Self-reported hearing difficulties among adults with normal audiograms: The Beaver Dam offspring study. Ear and Hearing, doi:10.1097/AUD.0000000000000195.
Tufts, J. B., Jahn, K. N., & Byram, J. P. (2013). Consistency of attenuation across multiple fittings of custom and non-custom earplugs. Annals of Occupational Hygiene, 57(5), 571–580.
University of California Technology Transfer Office. (2015). The Bayh-Dole Act: A guide to the law and implementing regulations. http://www.ucop.edu/ott/faculty/bayh.html. Accessed July 9, 2015.
US Food and Drug Administration. (April 28, 2015). Dietary supplements. http://www.fda.gov/Food/DietarySupplements/UsingDietarySupplements/ucm109760.htm. Accessed July 1, 2016.
US Food and Drug Administration. (2002, May 27, 2015). Guidance for industry: Structure/function claims, small entity compliance guide. http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/DietarySupplements/ucm103340.htm. Accessed August 6, 2015.
Valente, M. (2005). Using evidence-based principles to make clinical decisions. Journal of the American Academy of Audiology, 16(10), 768–769.
Voix, J., & Hager, L. D. (2009). Individual fit testing of hearing protection devices. International Journal of Occupational Safety and Ergonomics, 15(2), 211–219.
Westfall, J. M., Mold, J., & Fagnan, L. (2007). Practice-based research—“Blue Highways” on the NIH roadmap. JAMA, 297(4), 403–406.
Wilson, R. H. (2011). Clinical experience with the words-in-noise test on 3430 veterans: Comparisons with pure-tone thresholds and word recognition in quiet. Journal of the American Academy of Audiology, 22(7), 405–423.
Woolf, S. H. (2008). The meaning of translational research and why it matters. JAMA, 299(2), 211–213.
Yamane, H., Nakai, Y., Takayama, M., Iguchi, H., Nakagawa, T., & Kojima, A. (1995). Appearance of free radicals in the guinea pig inner ear after noise-induced acoustic trauma. European Archives of Oto-Rhino-Laryngology, 252(8), 504–508.
Yamashita, D., Jiang, H., Schacht, J., & Miller, J. M. (2004). Delayed production of free radicals following noise exposure. Brain Research, 1019, 201–209.
Acknowledgments
Translational research must be approached as team science, with scientists, clinicians, physicians, statisticians, experts in the regulatory rules and IND preparation, and, of course, a clinical trial manager all contributing important pieces. I am grateful to the many friends and colleagues who have partnered with me on the studies described in this chapter, including Patrick Antonelli, Edward Lobarinas, Christopher Spankovich, Scott Griffiths, and Leigh Anne Marshall at the University of Florida; Josef Miller, Glenn Green, Bill Reisdorph, and Kenneth Guire at the University of Michigan; Kathleen Campbell at Southern Illinois University; Eric Lynch and Jonathon Kil at Sound Pharmaceuticals, Inc., and Matt Klein and Erin Johnson at Edison Pharmaceuticals, Inc. I appreciate helpful comments on an earlier version of this manuscript from Edward Lobarinas, Art Popper, and Jianxin Bao.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Compliance with Ethics Requirements
Colleen Le Prell has received contract funding from industry sources including Sound Pharmaceuticals, Inc., Edison Pharmaceuticals, Inc., Hearing Health Sciences, Inc., and MaxSound, Inc. She is a co-inventor on patents assigned to the University of Michigan and the University of Florida.
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Le Prell, C.G. (2016). Current Issues in Clinical and Translational Research in the Hearing Sciences, Audiology, and Otolaryngology. In: Le Prell, C., Lobarinas, E., Popper, A., Fay, R. (eds) Translational Research in Audiology, Neurotology, and the Hearing Sciences. Springer Handbook of Auditory Research, vol 58. Springer, Cham. https://doi.org/10.1007/978-3-319-40848-4_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-40848-4_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-40846-0
Online ISBN: 978-3-319-40848-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)